Next Article in Journal
Beta vulgaris Betalains Mitigate Parasitemia and Brain Oxidative Stress Induced by Plasmodium berghei in Mice
Next Article in Special Issue
Enhanced Anti-Obesity Effects of Euphorbia Kansui Extract through Macrophage and Gut Microbiota Modulation: A Real-World Clinical and In Vivo Study
Previous Article in Journal
Neuroprotective Effects of Phenolic Constituents from Drynariae Rhizoma
Previous Article in Special Issue
Medicinal Plant Extracts against Cardiometabolic Risk Factors Associated with Obesity: Molecular Mechanisms and Therapeutic Targets
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceuticals
Volume 17
Issue 8
10.3390/ph17081062
pharmaceuticals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Lipid-Lowering and Anti-Inflammatory Effects of Campomanesia adamantium Leaves in Adipocytes and Caenorhabditis elegans

by
Paola dos Santos da Rocha
†,
Sarah Lam Orué
†,
Isamara Carvalho Ferreira
,
Priscilla Pereira de Toledo Espindola
,
Maria Victória Benites Rodrigues
,
José Tarcísio Giffoni de Carvalho
,
Debora da Silva Baldivia
,
Daniel Ferreira Leite
,
Helder Freitas dos Santos
,
Alex Santos Oliveira
,
Jaqueline Ferreira Campos
,
Edson Lucas dos Santos
and
Kely de Picoli Souza
*
Research Group on Biotechnology and Bioprospecting Applied to Metabolism (GEBBAM), Federal University of Grande Dourados, Rodovia Dourados-Itahum, Km 12, Dourados 79804-970, MS, Brazil
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Pharmaceuticals 2024, 17(8), 1062; https://doi.org/10.3390/ph17081062
Submission received: 23 July 2024 / Revised: 5 August 2024 / Accepted: 8 August 2024 / Published: 13 August 2024
(This article belongs to the Special Issue Anti-obesity and Anti-aging Natural Products)
Browse Figures
Versions Notes

Abstract

:
Obesity is a pandemic disease characterized by lipid accumulation, increased proinflammatory cytokines, and reactive oxygen species. It is associated with the development of comorbidities that lead to death. Additionally, drug treatments developed to control obesity are insufficient and have a variety of adverse effects. Thus, the search for new anti-obesity therapies is necessary. Campomanesia adamantium is a species from the Brazilian Cerrado that has the potential to treat obesity, as described by the antihyperlipidemic activity of its roots. Therefore, this study aimed to investigate the activity of the aqueous extract of C. adamantium leaves (AECa) on the control of reactive species in vitro, on lipid accumulation in adipocytes and Caenorhabditis elegans, and on the production of proinflammatory cytokines in adipocytes. The antioxidant capacity of AECa was observed by its action in scavenging DPPH• free radical, iron-reducing power, and inhibition of β-carotene bleaching. AECa reduced lipid accumulation in preadipocytes and in C. elegans. Moreover, AECa reduced the production of the proinflammatory cytokines MCP-1, TNF-α, and IL-6 in adipocytes. In summary, the antioxidant activity and the ability of AECa to reduce the accumulation of lipids and proinflammatory cytokines indicate, for the first time, the anti-obesity potential of C. adamantium leaves.

Graphical Abstract

1. Introduction

Obesity is a pandemic chronic inflammatory disease, mainly due to unhealthy eating and a sedentary lifestyle. It is currently the leading nutritional disorder in developed countries [1]. Obesity is characterized by the expansion of white adipose tissue, resulting from the processes of adipogenesis and lipogenesis, which are characteristics of adipocyte hyperplasia and hypertrophy, respectively [2]. Adipogenesis is upregulated in the mesenchymal stem cells of adipose tissue by fatty acid-activated transcription factors, which include PPAR-γ [3]. Furthermore, the activation of PPAR-γ in adipocytes also promotes the sensitivity of these cells to insulin, promoting the absorption of glucose and the accumulation of lipids through a process known as lipogenesis [4]. For lipid accumulation during lipogenesis, transcriptional factors, including SREBP-1c, are activated [5].
In addition, adipocyte hypertrophy contributes to the production of proinflammatory cytokines such as interleukin 6 (IL-6) and tumor necrosis factor-alpha (TNF-α) and increases the secretion of chemokines such as monocyte chemoattractant protein 1 (MCP-1) [6]. Hypertrophy upregulates a cycle of continuous cellular recruitment of inflammation that leads to the increased production of reactive oxygen species [7]. If not neutralized, these reactive oxygen species generate an oxidative stress condition. The inflammatory and oxidative stress conditions in adipocytes that characterize obesity are associated with the development of comorbidities such as type 2 diabetes, cardiovascular disease, and cancer, which are among the leading causes of death in the world today [8].
Drug treatments developed to control obesity are insufficient and have several adverse effects [9]. Therapeutic alternatives are, therefore, being sought to obtain products that modulate adipogenesis, lipogenesis, and the production of proinflammatory cytokines and possess antioxidant activities.
Among the therapeutic alternatives, medicinal plants have gained prominence for their biological activities, with fewer adverse effects and low costs to public health [10]. Campomanesia adamantium O. Berg, popularly known as guavira, is a medicinal plant from the Myrtaceae family, native to the Brazilian Cerrado [11]. C. adamantium is traditionally used to treat diarrhea, urinary tract infections, and stomach disorders [11]. Its biological properties include anti-inflammatory, pro-longevity, and cyclooxygenase-inhibiting activities [12,13,14].
In a previous study, we verified the antioxidant and antihyperlipidemic effects of Campomanesia adamantium O. Berg roots [15]. Furthermore, another study found that the aqueous extract of C. adamantium leaves has quinic acid and phenolic compounds, such as flavonoids, with myricetin and quercetin as its main constituents [16]. Therefore, in this study, we investigated the effect of C. adamantium leaves on controlling reactive oxygen species, lipid accumulation, and the production of proinflammatory cytokines.

2. Results

2.1. Antioxidant Activity of AECa

AECa showed antioxidant activity observed by the DPPH•, FRAP, and β-carotene bleaching methods (Table 1). The concentration of AECa capable of inhibiting 50% (IC50) of DPPH• radicals was approximately 1.6 times higher than that of the Controls, ascorbic acid, and BHA. The FRAP test’s average effective concentration (EC50) of AECa was approximately 1.4 times higher than ascorbic acid. In the β-carotene bleaching test, AECa had an IC50 approximately 15 times higher than BHA, and a value the IC50 of ascorbic acid was not detected (Table 1).

2.2. Effect of AECa on Preadipocytes

AECa did not reduce the viability of preadipocytes regardless of the concentration at 24 h. At 48 h, the concentrations of AECa maintained viability above 90% (Figure 1).

2.3. Effect of AECa on Lipid Accumulation in Cells

The induction of differentiation using adipogenic medium in preadipocytes increased lipid content by 35% compared to the lipid content of undifferentiated cells (Control). AECa prevented lipid accumulation in a concentration-independent manner by approximately 31% compared to the cells differentiated using adipogenic medium (Figure 2A,B).
In differentiated adipocytes, AECa reduced lipid accumulation by approximately 30%, 25%, and 19% at 12.5, 25, and 50 µg/mL concentrations, respectively, compared to the Control (Figure 2C).

2.4. Effect of AECa on Cytokine Production

The induction of differentiation by the adipogenic medium in preadipocytes increased the production of the proinflammatory cytokines MCP-1, TNF-α, and IL-6 compared to undifferentiated cells (Control). AECa reduced MCP-1 production by 13, 27, and 43% at 25, 50, and 100 µg/mL concentrations, respectively. AECa reduced TNF-α production by approximately 25%. AECa reduced IL-6 production by 37 and 50% at concentrations of 50 and 100 µg/mL. AECa did not alter the production of the anti-inflammatory cytokine IL-10 (Figure 3).

2.5. Effect of AECa on Caenorhabditis elegans Nematodes

AECa did not alter the viability of the nematode C. elegans, except at a concentration of 1000 µg/mL over 24 h, where viability remained above 85%. At 48 h, the highest concentrations of AECa (750 and 1000 µg/mL) kept the viability of the nematodes above 75% (Figure 4A).
AECa reduced the lipid content in C. elegans by approximately 20% and 24% at concentrations of 250 and 500 µg/mL, respectively, compared to the Control (Figure 4B,C).

3. Discussion

This study reports, for the first time, the ability of the aqueous extract of C. adamantium leaves to reduce lipid content in preadipocytes, and in the in vivo model C. elegans, the production of proinflammatory cytokines in these cells, besides its antioxidant activity in vitro. In a previous study, we found that the main phytochemical constituents of AECa are quinic acid and phenolic compounds such as myricetin and quercetin [16]. Phenolic compounds are widely described for their antioxidant potential, as they have a chemical structure consisting of an aromatic ring and free hydroxyls that confer on them the ability to donate hydrogen and electrons [17,18]. AECa showed antioxidant activity in the DPPH•, FRAP, and β-carotene bleaching assays, probably mediated by donating electrons from its phenolic compounds to stabilize radical molecules, reduce stable molecules, and prevent oxidative processes in lipids, respectively.
In addition, some phenolic compounds have been described as having anti-obesity potential, either through their ability to reduce adipogenesis and lipogenesis or to activate lipolysis [19,20,21]. In this study, we found that AECa reduced lipid accumulation when preadipocytes were treated with the extract simultaneously with the induction of differentiation with adipogenic medium. This reduction occurred in a concentration-independent manner of the AECa, which is probably related to the maximum sustained activity of the active compound in the extract, as observed for other plant extracts [22]. Probably, the AECa lowers adipogenesis (reduced differentiation) or reduces lipogenesis in differentiated cells, as some compounds present in AECa, such as quercetin and myricetin, have already been described as negative regulators of adipogenic and lipogenic genes and transcription factors such as PPAR-γ and SREBP-1c [23,24]. In this way, we can suggest that the effect of AECa is related to the group of compounds present in the extract that probably promote a reduction in the differentiation and lipogenesis of preadipocytes and adipocytes, respectively.
Additionally, AECa was able to promote lipolysis in differentiated and hypertrophied cells. Among the compounds in the extract, quercetin and myricetin may be associated with the lipolytic potential observed, as they have already been described in other studies for their lipolytic activity in adipocytes [23,25,26]. In a study by Yun-Soo et al. [25], quercetin promoted lipolysis by increasing the expression of hormone-sensitive lipase (HSL). In another study, Brasaemle et al. [26] found that myricetin downregulated the expression of perilipin A, the most abundant protein associated with lipid droplets in adipocytes that control basal and stimulated lipolysis [27].
The progression of obesity and its comorbidities is directly related to the increased production of proinflammatory cytokines and reduced production of anti-inflammatory cytokines [28]. In obesity, hypertrophied adipose tissue is accompanied by inadequate vascularization, making the cells dysfunctional and hypoxic and consequently increasing the production of proinflammatory cytokines, promoting immune cell recruitment [29]. Proinflammatory cytokines produced by immune cells and secreted by the adipose tissue, such as TNF-α, IL-4, and IL-6, stimulate obesity-associated diseases, including insulin resistance, dyslipidemia, and cardiovascular diseases. These comorbidities are related to the increased production of reactive oxygen species, which characterizes obesity-related oxidative stress [30,31,32,33]. Therefore, the in vitro antioxidant activity observed in this study may contribute to reducing the damage caused by obesity, as already observed in other studies [34].
AECa reduced the production of proinflammatory cytokines in the hypertrophied adipocytes in this study, which was probably mediated by the phenolic compounds and quinic acid present in AECa. In other studies, compounds present in AECa, such as phenolic compounds and quinic acid, have been shown to modulate cytokines such as TNF-α, IL-6, and MCP-1 [35,36,37]. Quinic acid, quercetin, and myricetin reduce TNF-α and IL-6 production levels by blocking the nuclear translocation of nuclear factor-κB [35,36]. Additionally, quercetin reduces the levels of MCP-1 in vitro and in vivo [37].
In the same way that AECa reduced lipid content in cells, it also reduced lipid accumulation in C. elegans, a complete organism. This free-living nematode is widely used as a model organism for evaluating the effect of different substances due to genes homologous to humans [38] and has been suggested as a model for obesity and drug studies [39]. C. elegans does not have adipocytes, so the lipid droplets are stored mainly in intestinal cells, called enterocytes. The lipid droplets of C. elegans mainly store triglycerides and cholesterol esters [40]. Lipid storage in C. elegans occurs through the activation of pathways orthologous to human pathways related to lipid metabolism, such as SBP-1, and those orthologous to SREBP [41].
In our study, C. elegans nematodes were treated with AECa from the first larval stage after the eggs had hatched. Therefore, the reduction in lipid content observed in the nematode intestinal cells is probably related to the suppression of the SBP-1 pathway by the compounds present in the extract. As previously mentioned, compounds present in AECa, such as myricetin, have been reported to modulate SREBP-1c negatively [42]. Moreover, another study observed that quercetin and myricetin reduced the lipid content in C. elegans [42].
Additionally, lipolysis in C. elegans can be mediated by hormone-sensitive lipase (HSL) [41]. As we saw earlier, among the compounds present in the extract, quercetin may be associated with the lipolytic potential observed by increasing the expression of HSL [23,25], thereby contributing to the reduction in the lipid content in C. elegans once the nematodes were treated until the L4 stage.
In conclusion, our results indicate that the aqueous extract of C. adamantium leaves has anti-obesity potential, with the ability to reduce adipogenesis and lipogenesis, activate lipolysis, and reduce the inflammatory processes and oxidative stress associated with the development and progression of obesity and its comorbidities.

4. Materials and Methods

4.1. Plant Material and Extract Preparation

C. adamantium O. Berg leaves were collected after authorization from SISBIO (Biodiversity Authorization and Information System, number 54470) in Dourados, Mato Grosso do Sul, Brazil (coordinates: 22°02′47.9″ S and 055°08′14.3″ W). An exsiccate was deposited in the Herbarium of the Federal University of Grande Dourados, Mato Grosso do Sul, Brazil (DDMS registration number 4108). The leaves were sanitized, dried in an air circulation oven at 45 °C, and pulverized in a knife mill. The aqueous extract of C. adamantium leaves (AECa) was prepared as described by Espindola et al. [15].

4.2. Evaluation of the Antioxidant Activity of AECa

4.2.1. DPPH• Free Radical Scavenging Assay

The antioxidant capacity of AECa was evaluated using the 2,2-Diphenyl-1-picrylhydrazyl (DPPH•) free radical capture method described by Bobo-García et al. [43]. Briefly, 20 µL of AECa (10–1000 µg/mL) was mixed with 180 µL of DPPH• 150 µmol/L solution and incubated for 40 min at room temperature in the dark. The absorbance was measured at 515 nm. The Control consisted of 20 µL of distilled water and 180 µL of DPPH• solution. Ascorbic acid and 2,3-tert-butyl-4-hydroxyanisole (BHA) (10–1000 µg/mL) were used as the standards. Three independent experiments were carried out in triplicate. The DPPH• inhibition percentage was obtained using the following equation:
DPPH• inhibition (%) = (1 − Absextract/Abscontrol) × 100.
The free radical 50% inhibition values (IC50) were calculated.

4.2.2. Ferric Reducing Antioxidant Power (FRAP) Assay

The antioxidant capacity was assessed by its potential to reduce iron, as described by Ustundag et al. [44]. Briefly, 20 µL of AECa (20–200 µg/mL) was mixed with 280 µL of FRAP reagent. The mixture was incubated at 37 °C for 30 min. The absorbance was measured at 593 nm. The Control consisted of 20 µL of distilled water mixed with 280 µL of the FRAP reagent. BHA (20–200 µg/mL) was used as a standard. Three independent experiments were carried out in triplicate. The mean effective concentration (EC50) values of the extract were calculated.

4.2.3. β-Carotene Bleaching Inhibitory Activity Assay

The antioxidant capacity was evaluated by inhibiting the bleaching of β-carotene, resulting from the oxidation induced by linoleic acid degradation products, as described by Koleva et al. [45] and Rocha et al. [46]. Briefly, 30 µL of AECa (100–1000 µg/mL) was mixed with 250 µL of β-carotene emulsion. The mixture was stirred and the absorbance was measured at 492 nm immediately after adding the emulsion (Abs1). The mixture was kept at 50 °C under stirring for 120 min. The absorbance was measured at 492 nm (Abs2). The Control consisted of 30 µL of distilled water and 250 µL of the emulsion. BHA was used as a standard (1–100 µg/mL). Three independent experiments were carried out in triplicate. The percentage of inhibition of β-carotene bleaching in the samples was obtained using the following equation:
Inhibition of β-carotene bleaching (%) = [1 − (Abs2extract − Abs1extract)/(Abs2control − Abs1control)] × 100.
IC50 values were calculated.

4.3. Evaluation of the Effect of AECa on Preadipocytes and Adipocytes

4.3.1. Cell Culture

Preadipocytes (3T3-F442A cells) were grown to 90% confluence in high-glucose Dulbecco’s Modified Medium (DMEM) containing 3.7 g/L of sodium bicarbonate and 5.77 g/L of HEPES, supplemented with 10% Fetal Bovine Serum (FBS) and 1% penicillin/streptomycin (10,000 U mL−1), all from Gibco/Invitrogen, Minneapolis, MN, USA. The cells were kept at 37 °C in a humidified atmosphere of 5% CO2.

4.3.2. Cell Viability Assay Using MTT

Preadipocytes were plated in 96-well microplates (6 × 103 cells/well) and incubated for 24 h. After this period, different concentrations of AECa (3.12–100 µg/mL) were added to the cell culture medium, and the cells were incubated for 24 h and 48 h. Subsequently, the cells were incubated for 4 h with 1 mg/mL of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). The reduction in MTT in the mitochondria resulted in the formation of violet-colored formazan crystals, which were dissolved in DMSO (100 μL/well), and the absorbance was measured at 630 nm in a microplate reader. Three independent experiments were performed in triplicate.

4.3.3. Lipid Accumulation in Cells

The effect of AECa on preadipocytes was evaluated according to the methods described by Elfakhani et al. [47] with modifications. For this purpose, preadipocytes were plated in 6-well plates (1 × 104 cells/well). When 70% confluence was reached (day 0), the adipogenic medium was added for differentiation: cell culture medium, insulin 5 µg/mL, and rosiglitazone 3 mM.
To assess the antiadipogenic effect of AECa, the cells induced to differentiate with the adipogenic medium were simultaneously given different concentrations of AECa (25–100 µg/mL) on day 0 and incubated for 48 h. The adipogenic medium without AECa was replaced every 48 h until day 8. In the end, the cells were fixed with 10% formaldehyde for 1 h and stained with a 0.3% Oil red solution for 30 min. The cells were photographed in representative fields with a camera attached to an inverted microscope at 400× magnification for analysis. The stained lipid content was removed with 100% isopropanol, and the absorbance was measured at 492 nm.
To assess the lipolytic effect of AECa, hypertrophied cells were treated with different concentrations of AECa (25–100 µg/mL) on day 8 after differentiation. After 48 h of treatment, the cells were fixed with 10% formaldehyde for 1 h and stained with a 0.3% Oil red solution for 30 min. The stained lipid content was removed with 100% isopropanol, and the absorbance was measured at 492 nm.
The cells in the Control group were incubated with the cell culture medium without the adipogenic medium while untreated cells induced to differentiation were incubated with the adipogenic medium. Two independent experiments were performed in duplicate.

4.3.4. Cytokine Quantification

To evaluate the effect of AECa on cytokine production (MCP-1, TNF-α, IL-6, and IL-10), the cells were treated with different concentrations of AECa (25–100 µg/mL) on day 0. On day 8, the adipocyte supernatant was collected and subjected to the Cytometric Bead Array (CBA) method (BD Biosciences). The evaluation was carried out by Flow Cytometry (BD LSRFortessa, BD biosciences) according to the manufacturer’s instructions, and analysis was performed using the (BD biosciences). Two independent experiments were performed in duplicate.

4.4. Evaluation of the Effect of AECa on Caenorhabditis elegans

4.4.1. C. elegans Culture

The in vivo tests were carried out using the wild strain N2 of the nematode C. elegans, obtained from the Caenorhabditis Genetics Center (CGC), Minneapolis, MN, USA. The nematodes were incubated at 20 °C in Petri dishes containing nematode growth medium (NGM) and fed with Escherichia coli OP50 bacteria, inactivated with 10 mM kanamycin antibiotic. The nematodes were synchronized for the tests with an alkaline medium containing 2% sodium hypochlorite and 5 M sodium hydroxide. Eggs resistant to alkaline lysis were transferred to Petri dishes containing NGM and E. coli.

4.4.2. Sub-Chronic Toxicity

The effect of AECa on the viability of C. elegans was evaluated according to the method described by Leite et al. [48]. Briefly, the nematodes were synchronized at the L4 stage of development (10 nematodes N2/well) and transferred to 96-well microplates containing 100 μL of M9 buffer and 100 μL of AECa at different concentrations (3.1–100 μg/mL). The nematodes were incubated at 20 °C for 24 h and 48 h. The nematodes in the Control group were incubated with M9 buffer (200 μL). In the end, nematode viability was assessed by touch sensitivity using a platinum wire. Three independent experiments were carried out in triplicate.

4.4.3. Lipid Accumulation in C. elegans

For the quantification of lipids in C. elegans, the method described by Escorcia et al. [49] was used. For this purpose, synchronized C. elegans nematodes (L1 stage) were transferred to Petri dishes containing NGM and 300 μL of different concentrations of AECa (250–500 μg/mL) diluted in E. coli OP50. Upon reaching the L4 stage of development (approximately 48 h after synchronization), the nematodes were stained with 0.3% Oil red for 2 h. In the end, a slide was prepared with a volume of 5 µL, covered with a coverslip, and photographed under a microscope at 100× magnification. The images were analyzed using the ImageJ (version 1.52a) program. Three independent experiments were performed in duplicate.

4.5. Statistical Analysis

The data obtained were expressed as means ± standard error of the mean (SEM). Analysis of variance (ANOVA) with a Newman–Keuls post-test in GraphPad Prism 9 software (San Diego, CA, USA) was used to analyze and compare the experimental groups. The results were considered significant when p < 0.05.

Author Contributions

Conceptualization, P.d.S.d.R., S.L.O., I.C.F., M.V.B.R., J.F.C., E.L.d.S., and K.d.P.S.; methodology, P.d.S.d.R., S.L.O., I.C.F., P.P.d.T.E., M.V.B.R., J.T.G.d.C., D.d.S.B., D.F.L., H.F.d.S., and A.S.O.; software, P.d.S.d.R., S.L.O., I.C.F., P.P.d.T.E., M.V.B.R., J.F.C., E.L.d.S., and K.d.P.S.; validation, P.d.S.d.R., S.L.O., J.T.G.d.C., D.d.S.B., J.F.C., E.L.d.S., and K.d.P.S.; formal analysis, P.d.S.d.R., S.L.O., J.T.G.d.C., J.F.C., E.L.d.S., and K.d.P.S.; investigation, P.d.S.d.R., S.L.O., I.C.F., M.V.B.R., J.T.G.d.C., D.d.S.B., D.F.L., H.F.d.S., A.S.O., J.F.C., E.L.d.S., and K.d.P.S.; resources, J.F.C., E.L.d.S., and K.d.P.S.; data curation, P.d.S.d.R., S.L.O., J.T.G.d.C., J.F.C., E.L.d.S., and K.d.P.S.; writing—original draft preparation, P.d.S.d.R., S.L.O., I.C.F., M.V.B.R., D.d.S.B., D.F.L., H.F.d.S., A.S.O., J.F.C., E.L.d.S., and K.d.P.S.; writing—review and editing, P.d.S.d.R., S.L.O., I.C.F., M.V.B.R., J.T.G.d.C., D.d.S.B., D.F.L., H.F.d.S., A.S.O., J.F.C., E.L.d.S., and K.d.P.S.; visualization, P.d.S.d.R., S.L.O., J.T.G.d.C., D.d.S.B., J.F.C., E.L.d.S., and K.d.P.S.; supervision, J.F.C., E.L.d.S., and K.d.P.S.; project administration, J.F.C., E.L.d.S., and K.d.P.S.; funding acquisition, J.F.C., E.L.d.S., and K.d.P.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT), Pró-Reitoria de Ensino de Pós-Graduação e Pesquisa da Universidade Federal da Grande Dourados (PROPP-UFGD); Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Conselho Nacional de Desenvolvimento Científico e Tecnológic (CNPq); and Financiadora de Estudos e Projetos (Finep). The APC was funded by FUNDECT grant number TO 230/2022.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available upon request from the corresponding author.

Acknowledgments

This work was supported by Pró-Reitoria de Ensino de Pós-Graduação e Pesquisa da Universidade Federal da Grande Dourados (PROPP-UFGD); Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT); Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Conselho Nacional de Desenvolvimento Científico e Tecnológic (CNPq); and Financiadora de Estudos e Projetos (Finep).

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Jakab, J.; Miškić, B.; Mikšić, Š.; Juranić, B.; Ćosić, V.; Schwarz, D.; Včev, A. Adipogenesis as a Potential Anti-Obesity Target: A Review of Pharmacological Treatment and Natural Products. Diabetes Metab. Syndr. Obes. Targets Ther. 2021, 14, 67–83. [Google Scholar] [CrossRef] [PubMed]
  2. Jo, J.; Gavrilova, O.; Pack, S.; Jou, W.; Mullen, S.; Sumner, A.E.; Cushman, S.W.; Periwal, V. Hypertrophy and/or Hyperplasia: Dynamics of Adipose Tissue Growth. PLoS Comput. Biol. 2009, 5, e1000324. [Google Scholar] [CrossRef] [PubMed]
  3. Kershaw, E.E.; Schupp, M.; Guan, H.-P.; Gardner, N.P.; Lazar, M.A.; Flier, J.S. PPARγ Regulates Adipose Triglyceride Lipase in Adipocytes in Vitro and in Vivo. Am. J. Physiol. Metab. 2007, 293, E1736–E1745. [Google Scholar] [CrossRef] [PubMed]
  4. Janani, C.; Ranjitha Kumari, B.D. PPAR Gamma Gene—A Review. Diabetes Metab. Syndr. Clin. Res. Rev. 2015, 9, 46–50. [Google Scholar] [CrossRef] [PubMed]
  5. Shimano, H. SREBPs: Physiology and Pathophysiology of the SREBP Family. FEBS J. 2009, 276, 616–621. [Google Scholar] [CrossRef] [PubMed]
  6. Monserrat-Mesquida, M.; Quetglas-Llabrés, M.; Capó, X.; Bouzas, C.; Mateos, D.; Pons, A.; Tur, J.A.; Sureda, A. Metabolic Syndrome Is Associated with Oxidative Stress and Proinflammatory State. Antioxidants 2020, 9, 236. [Google Scholar] [CrossRef] [PubMed]
  7. Monteiro, R.; Azevedo, I. Chronic Inflammation in Obesity and the Metabolic Syndrome. Mediat. Inflamm. 2010, 2010, 289645. [Google Scholar] [CrossRef] [PubMed]
  8. Salmon, A. Beyond Diabetes: Does Obesity-Induced Oxidative Stress Drive the Aging Process? Antioxidants 2016, 5, 24. [Google Scholar] [CrossRef]
  9. Heymsfield, S.B.; Wadden, T.A. Mechanisms, Pathophysiology, and Management of Obesity. N. Engl. J. Med. 2017, 376, 254–266. [Google Scholar] [CrossRef]
  10. Saad, B.; Zaid, H.; Shanak, S.; Kadan, S. Introduction to Medicinal Plant Safety and Efficacy. In Anti-Diabetes and Anti-Obesity Medicinal Plants and Phytochemicals; Springer International Publishing: Cham, Switzerland, 2017; pp. 21–55. [Google Scholar] [CrossRef]
  11. Cardoso, C.A.L. Plantas Do Gênero Campomanesia: Potenciais Medicinal e Nutracêutico; Carvalho, E.S.d., Ed.; UEMS: Dourados, Brazil, 2021. [Google Scholar]
  12. Lescano, C.H.; Freitas de Lima, F.; Mendes-Silvério, C.B.; Justo, A.F.O.; da Silva Baldivia, D.; Vieira, C.P.; Sanjinez-Argandoña, E.J.; Cardoso, C.A.L.; Mónica, F.Z.; Pires de Oliveira, I. Effect of Polyphenols from Campomanesia adamantium on Platelet Aggregation and Inhibition of Cyclooxygenases: Molecular Docking and in Vitro Analysis. Front. Pharmacol. 2018, 9, 617. [Google Scholar] [CrossRef]
  13. Ferreira, L.C.; Grabe-Guimarães, A.; de Paula, C.A.; Michel, M.C.P.; Guimarães, R.G.; Rezende, S.A.; de Souza Filho, J.D.; Saúde-Guimarães, D.A. Anti-Inflammatory and Antinociceptive Activities of Campomanesia adamantium. J. Ethnopharmacol. 2013, 145, 100–108. [Google Scholar] [CrossRef]
  14. de Araújo, L.C.A.; Leite, N.R.; Rocha, P.d.S.d.; Baldivia, D.d.S.; Agarrayua, D.A.; Ávila, D.S.; da Silva, D.B.; Carollo, C.A.; Campos, J.F.; Souza, K.d.P.; et al. Campomanesia adamantium O Berg. Fruit, Native to Brazil, Can Protect against Oxidative Stress and Promote Longevity. PLoS ONE 2023, 18, e0294316. [Google Scholar] [CrossRef] [PubMed]
  15. Espindola, P.P.d.T.; Rocha, P.d.S.d.; Carollo, C.A.; Schmitz, W.O.; Pereira, Z.V.; Vieira, M.D.C.; dos Santos, E.L.; Souza, K.d.P. Antioxidant and Antihyperlipidemic Effects of Campomanesia adamantium O. Berg Root. Oxid. Med. Cell. Longev. 2016, 2016, 7910340. [Google Scholar] [CrossRef] [PubMed]
  16. Campos, J.F.; Espindola, P.P.d.T.; Torquato, H.F.V.; Vital, W.D.; Justo, G.Z.; Silva, D.B.; Carollo, C.A.; Souza, K.d.P.; Paredes-Gamero, E.J.; dos Santos, E.L. Leaf and Root Extracts from Campomanesia adamantium (Myrtaceae) Promote Apoptotic Death of Leukemic Cells via Activation of Intracellular Calcium and Caspase-3. Front. Pharmacol. 2017, 8, 466. [Google Scholar] [CrossRef]
  17. Platzer, M.; Kiese, S.; Tybussek, T.; Herfellner, T.; Schneider, F.; Schweiggert-Weisz, U.; Eisner, P. Radical Scavenging Mechanisms of Phenolic Compounds: A Quantitative Structure-Property Relationship (QSPR) Study. Front. Nutr. 2022, 9, 882458. [Google Scholar] [CrossRef]
  18. Anttonen, M.J.; Karjalainen, R.O. High-Performance Liquid Chromatography Analysis of Black Currant (Ribes nigrum L.) Fruit Phenolics Grown Either Conventionally or Organically. J. Agric. Food Chem. 2006, 54, 7530–7538. [Google Scholar] [CrossRef] [PubMed]
  19. Gómez-Zorita, S.; Lasa, A.; Abendaño, N.; Fernández-Quintela, A.; Mosqueda-Solís, A.; Garcia-Sobreviela, M.P.; Arbonés-Mainar, J.M.; Portillo, M.P. Phenolic Compounds Apigenin, Hesperidin and Kaempferol Reduce in Vitro Lipid Accumulation in Human Adipocytes. J. Transl. Med. 2017, 15, 237. [Google Scholar] [CrossRef]
  20. Aranaz, P.; Navarro-Herrera, D.; Zabala, M.; Romo-Hualde, A.; López-Yoldi, M.; Vizmanos, J.L.; Milagro, F.I.; González-Navarro, C.J. Phenolic Compounds Reduce the Fat Content in Caenorhabditis elegans by Affecting Lipogenesis, Lipolysis, and Different Stress Responses. Pharmaceuticals 2020, 13, 355. [Google Scholar] [CrossRef]
  21. dos Santos da Rocha, P.; Orué, S.L.; Leite, D.F.; de Toledo Espindola, P.P.; Cassemiro, N.S.; da Silva, D.B.; Carollo, C.A.; Nunes-Souza, V.; Rabelo, L.A.; Campos, J.F.; et al. Beneficial Effects of Bauhinia rufa Leaves on Oxidative Stress, Prevention, and Treatment of Obesity in High-Fat Diet-Fed C57BL/6 Mice. Oxid. Med. Cell. Longev. 2022, 2022, 8790810. [Google Scholar] [CrossRef]
  22. Oh, M.-J.; Lee, H.-B.; Yoo, G.; Park, M.; Lee, C.-H.; Choi, I.; Park, H.-Y. Anti-Obesity Effects of Red Pepper (Capsicum annuum L.) Leaf Extract on 3T3-L1 Preadipocytes and High Fat Diet-Fed Mice. Food Funct. 2023, 14, 292–304. [Google Scholar] [CrossRef]
  23. Wang, Q.; Wang, S.; Yang, X.; You, P.; Zhang, W. Myricetin Suppresses Differentiation of 3 T3-L1 Preadipocytes and Enhances Lipolysis in Adipocytes. Nutr. Res. 2015, 35, 317–327. [Google Scholar] [CrossRef]
  24. Lee, C.W.; Seo, J.Y.; Lee, J.; Choi, J.W.; Cho, S.; Bae, J.Y.; Sohng, J.K.; Kim, S.O.; Kim, J.; Park, Y.I. 3-O-Glucosylation of Quercetin Enhances Inhibitory Effects on the Adipocyte Differentiation and Lipogenesis. Biomed. Pharmacother. 2017, 95, 589–598. [Google Scholar] [CrossRef]
  25. Yun-Soo, S.; Ok-Hwa, K.; Sung-Bae, K.; Su-Hyun, M.; Da-Hye, K.; Da-Wun, Y.; Jang-Gi, c.; Young-Mi, L.; Dae-Kil, K.; Ho-Seog, L.; et al. Quercetin Prevents Adipogenesis by Regulation of Transcriptional Factors and Lipases in OP9 Cells. Int. J. Mol. Med. 2015, 35, 1779–1785. [Google Scholar] [CrossRef]
  26. Brasaemle, D.L.; Subramanian, V.; Garcia, A.; Marcinkiewicz, A.; Rothenberg, A. Perilipin A and the Control of Triacylglycerol Metabolism. Mol. Cell. Biochem. 2009, 326, 15–21. [Google Scholar] [CrossRef]
  27. Sztalryd, C.; Brasaemle, D.L. The Perilipin Family of Lipid Droplet Proteins: Gatekeepers of Intracellular Lipolysis. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 2017, 1862, 1221–1232. [Google Scholar] [CrossRef] [PubMed]
  28. Fernández-Sánchez, A.; Madrigal-Santillán, E.; Bautista, M.; Esquivel-Soto, J.; Morales-González, Á.; Esquivel-Chirino, C.; Durante-Montiel, I.; Sánchez-Rivera, G.; Valadez-Vega, C.; Morales-González, J.A. Inflammation, Oxidative Stress, and Obesity. Int. J. Mol. Sci. 2011, 12, 3117–3132. [Google Scholar] [CrossRef] [PubMed]
  29. Wang, R.; Sun, Q.; Wu, X.; Zhang, Y.; Xing, X.; Lin, K.; Feng, Y.; Wang, M.; Wang, Y.; Wang, R. Hypoxia as a Double-Edged Sword to Combat Obesity and Comorbidities. Cells 2022, 11, 3735. [Google Scholar] [CrossRef] [PubMed]
  30. Hall, J.E.; Mouton, A.J.; da Silva, A.A.; Omoto, A.C.M.; Wang, Z.; Li, X.; do Carmo, J.M. Obesity, Kidney Dysfunction, and Inflammation: Interactions in Hypertension. Cardiovasc. Res. 2021, 117, 1859–1876. [Google Scholar] [CrossRef]
  31. Van Raemdonck, K.; Umar, S.; Szekanecz, Z.; Zomorrodi, R.K.; Shahrara, S. Impact of Obesity on Autoimmune Arthritis and Its Cardiovascular Complications. Autoimmun. Rev. 2018, 17, 821–835. [Google Scholar] [CrossRef]
  32. Matsuda, M.; Shimomura, I. Roles of Oxidative Stress, Adiponectin, and Nuclear Hormone Receptors in Obesity-Associated Insulin Resistance and Cardiovascular Risk. Horm. Mol. Biol. Clin. Investig. 2014, 19, 75–88. [Google Scholar] [CrossRef]
  33. Khan, S.S.; Ning, H.; Wilkins, J.T.; Allen, N.; Carnethon, M.; Berry, J.D.; Sweis, R.N.; Lloyd-Jones, D.M. Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity. JAMA Cardiol. 2018, 3, 280–287. [Google Scholar] [CrossRef] [PubMed]
  34. Khutami, C.; Sumiwi, S.A.; Khairul Ikram, N.K.; Muchtaridi, M. The Effects of Antioxidants from Natural Products on Obesity, Dyslipidemia, Diabetes and Their Molecular Signaling Mechanism. Int. J. Mol. Sci. 2022, 23, 2056. [Google Scholar] [CrossRef]
  35. Nam, S.-Y.; Han, N.-R.; Rah, S.-Y.; Seo, Y.; Kim, H.-M.; Jeong, H.-J. Anti-Inflammatory Effects of Artemisia scoparia and Its Active Constituent, 3,5-Dicaffeoyl-Epi-Quinic Acid against Activated Mast Cells. Immunopharmacol. Immunotoxicol. 2018, 40, 52–58. [Google Scholar] [CrossRef]
  36. Zhong, R.; Miao, L.; Zhang, H.; Tan, L.; Zhao, Y.; Tu, Y.; Angel Prieto, M.; Simal-Gandara, J.; Chen, L.; He, C.; et al. Anti-Inflammatory Activity of Flavonols via Inhibiting MAPK and NF-ΚB Signaling Pathways in RAW264.7 Macrophages. Curr. Res. Food Sci. 2022, 5, 1176–1184. [Google Scholar] [CrossRef]
  37. Le, N.H.; Kim, C.-S.; Park, T.; Park, J.H.Y.; Sung, M.-K.; Lee, D.G.; Hong, S.-M.; Choe, S.-Y.; Goto, T.; Kawada, T.; et al. Quercetin Protects against Obesity-Induced Skeletal Muscle Inflammation and Atrophy. Mediat. Inflamm. 2014, 2014, 834294. [Google Scholar] [CrossRef]
  38. Shen, P.; Yue, Y.; Zheng, J.; Park, Y. Caenorhabditis elegans: A Convenient In Vivo Model for Assessing the Impact of Food Bioactive Compounds on Obesity, Aging, and Alzheimer’s Disease. Annu. Rev. Food Sci. Technol. 2018, 9, 1–22. [Google Scholar] [CrossRef] [PubMed]
  39. Yue, Y.; Li, S.; Shen, P.; Park, Y. Caenorhabditis elegans as a Model for Obesity Research. Curr. Res. Food Sci. 2021, 4, 692–697. [Google Scholar] [CrossRef] [PubMed]
  40. Dyczkowska, A.; Chabowska-Kita, A. Caenorhabditis elegans as a Model Organism in Obesity Research. BioTechnologia 2021, 102, 337–362. [Google Scholar] [CrossRef]
  41. An, L.; Fu, X.; Chen, J.; Ma, J. Application of Caenorhabditis elegans in Lipid Metabolism Research. Int. J. Mol. Sci. 2023, 24, 1173. [Google Scholar] [CrossRef]
  42. Lin, Y.; Yang, N.; Bao, B.; Wang, L.; Chen, J.; Liu, J. Luteolin Reduces Fat Storage in Caenorhabditis elegans by Promoting the Central Serotonin Pathway. Food Funct. 2020, 11, 730–740. [Google Scholar] [CrossRef]
  43. Bobo-García, G.; Davidov-Pardo, G.; Arroqui, C.; Vírseda, P.; Marín-Arroyo, M.R.; Navarro, M. Intra-Laboratory Validation of Microplate Methods for Total Phenolic Content and Antioxidant Activity on Polyphenolic Extracts, and Comparison with Conventional Spectrophotometric Methods. J. Sci. Food Agric. 2015, 95, 204–209. [Google Scholar] [CrossRef] [PubMed]
  44. Ustundag, Y.; Huysal, K.; Kahvecioglu, S.; Demirci, H.; Yavuz, S.; Sambel, M.; Unal, D. Establishing Reference Values and Evaluation of an In-House Ferric Reducing Antioxidant Power (FRAP) Colorimetric Assay in Microplates. Eur. Res. J. 2016, 2, 126–131. [Google Scholar] [CrossRef]
  45. Koleva, I.I.; van Beek, T.A.; Linssen, J.P.H.; de Groot, A.; Evstatieva, L.N. Screening of Plant Extracts for Antioxidant Activity: A Comparative Study on Three Testing Methods. Phytochem. Anal. 2002, 13, 8–17. [Google Scholar] [CrossRef] [PubMed]
  46. Rocha, P.d.S.d.; de Araújo Boleti, A.P.; do Carmo Vieira, M.; Carollo, C.A.; da Silva, D.B.; Estevinho, L.M.; dos Santos, E.L.; de Picoli Souza, K. Microbiological Quality, Chemical Profile as Well as Antioxidant and Antidiabetic Activities of Schinus terebinthifolius Raddi. Comp. Biochem. Physiol. Part C Toxicol. Pharmacol. 2019, 220, 36–46. [Google Scholar] [CrossRef] [PubMed]
  47. Elfakhani, M.; Torabi, S.; Hussein, D.; Mills, N.; Verbeck, G.F.; Mo, H. Mevalonate Deprivation Mediates the Impact of Lovastatin on the Differentiation of Murine 3T3-F442A Preadipocytes. Exp. Biol. Med. 2014, 239, 293–301. [Google Scholar] [CrossRef] [PubMed]
  48. Leite, N.R.; de Araújo, L.C.A.; Rocha, P.d.S.d.; Agarrayua, D.A.; Ávila, D.S.; Carollo, C.A.; Silva, D.B.; Estevinho, L.M.; Souza, K.d.P.; dos Santos, E.L. Baru Pulp (Dipteryx alata Vogel): Fruit from the Brazilian Savanna Protects against Oxidative Stress and Increases the Life Expectancy of Caenorhabditis elegans via SOD-3 and DAF-16. Biomolecules 2020, 10, 1106. [Google Scholar] [CrossRef]
  49. Escorcia, W.; Ruter, D.L.; Nhan, J.; Curran, S.P. Quantification of Lipid Abundance and Evaluation of Lipid Distribution in Caenorhabditis elegans by Nile Red and Oil Red O Staining. J. Vis. Exp. 2018, 2018, e57352. [Google Scholar] [CrossRef]
Pharmaceuticals 17 01062 g001
Figure 1. Cellular viability of preadipocytes incubated with different concentrations (3.1, 6.25, 12.5, 25, 50, and 100 µg/mL) of aqueous extract of C. adamantium leaves (AECa): (A) 24 h and (B) 48 h. Results are expressed as means ± SEM. * p < 0.05 versus Control.
Figure 1. Cellular viability of preadipocytes incubated with different concentrations (3.1, 6.25, 12.5, 25, 50, and 100 µg/mL) of aqueous extract of C. adamantium leaves (AECa): (A) 24 h and (B) 48 h. Results are expressed as means ± SEM. * p < 0.05 versus Control.
Pharmaceuticals 17 01062 g001
Pharmaceuticals 17 01062 g002
Figure 2. Lipid content observed by the percentage of Oil red in preadipocytes and differentiated adipocytes treated with different concentrations (0, 25, 50, and 100 µg/mL) of aqueous extract of C. adamantium leaves (AECa): (A) percentage of Oil red in preadipocytes treated with AECa followed by an 8-day induction of differentiation; (B) photomicrographs of preadipocytes treated with AECa followed by an 8-day induction of differentiation at 400× magnification; (C) percentage of Oil red in adipocytes by an 8-day differentiation induction followed by 48 h AECa treatment. Results are expressed as means ± SEM. ### p < 0.001 versus Control; ** p < 0.01, *** p < 0.01 versus adipogenic medium (0 µg/mL).
Figure 2. Lipid content observed by the percentage of Oil red in preadipocytes and differentiated adipocytes treated with different concentrations (0, 25, 50, and 100 µg/mL) of aqueous extract of C. adamantium leaves (AECa): (A) percentage of Oil red in preadipocytes treated with AECa followed by an 8-day induction of differentiation; (B) photomicrographs of preadipocytes treated with AECa followed by an 8-day induction of differentiation at 400× magnification; (C) percentage of Oil red in adipocytes by an 8-day differentiation induction followed by 48 h AECa treatment. Results are expressed as means ± SEM. ### p < 0.001 versus Control; ** p < 0.01, *** p < 0.01 versus adipogenic medium (0 µg/mL).
Pharmaceuticals 17 01062 g002
Pharmaceuticals 17 01062 g003
Figure 3. Cytokine production in preadipocytes and hypertrophied adipocytes treated with different concentrations (0, 25, 50, and 100 µg/mL) of aqueous extract of C. adamantium leaves (AECa): (A) MCP-1; (B) TNF-α; (C) IL-6; and (D) IL-10. Results are expressed as means ± SEM. ## p < 0.01, ### p < 0.001, and #### p < 0.0001 versus Control; * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001 versus adipogenic medium.
Figure 3. Cytokine production in preadipocytes and hypertrophied adipocytes treated with different concentrations (0, 25, 50, and 100 µg/mL) of aqueous extract of C. adamantium leaves (AECa): (A) MCP-1; (B) TNF-α; (C) IL-6; and (D) IL-10. Results are expressed as means ± SEM. ## p < 0.01, ### p < 0.001, and #### p < 0.0001 versus Control; * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001 versus adipogenic medium.
Pharmaceuticals 17 01062 g003
Pharmaceuticals 17 01062 g004
Figure 4. Viability and lipid content of C. elegans treated with different concentrations (100, 200, 250, 500, 750, and 1000 µg/mL) of aqueous extract of C. adamantium leaves (AECa): (A) 24 h and 48 h; (B) lipids (area/average); (C) photomicrographs of C. elegans at 100× magnification. Results are expressed as means ± SEM. * p < 0.05 and **** p < 0.0001 versus Control.
Figure 4. Viability and lipid content of C. elegans treated with different concentrations (100, 200, 250, 500, 750, and 1000 µg/mL) of aqueous extract of C. adamantium leaves (AECa): (A) 24 h and 48 h; (B) lipids (area/average); (C) photomicrographs of C. elegans at 100× magnification. Results are expressed as means ± SEM. * p < 0.05 and **** p < 0.0001 versus Control.
Pharmaceuticals 17 01062 g004
Table 1. Antioxidant activity of aqueous extract of Campomanesia adamantium leaves (AECa).
Table 1. Antioxidant activity of aqueous extract of Campomanesia adamantium leaves (AECa).
SampleDPPH•FRAPβ-Carotene Bleaching
IC50 (µg/mL)EC50 (µg/mL)IC50 (µg/mL)
AECa10.41 ± 1.0656.54 ± 3.00229.87 ± 5.92
AA6.09 ± 2.2840.16 ± 4.96ND
BHA6.45 ± 2.28-15.14 ± 2.07
AA: ascorbic acid; BHA: butyl-4-hydroxyanisole; IC50: half-maximal inhibitory concentration; EC50: median effective concentration; -: not performed; ND: not detected. Results are expressed as means ± SEM.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Rocha, P.d.S.d.; Orué, S.L.; Ferreira, I.C.; Espindola, P.P.d.T.; Rodrigues, M.V.B.; Carvalho, J.T.G.d.; Baldivia, D.d.S.; Leite, D.F.; Santos, H.F.d.; Oliveira, A.S.; et al. Lipid-Lowering and Anti-Inflammatory Effects of Campomanesia adamantium Leaves in Adipocytes and Caenorhabditis elegans. Pharmaceuticals 2024, 17, 1062. https://doi.org/10.3390/ph17081062

AMA Style

Rocha PdSd, Orué SL, Ferreira IC, Espindola PPdT, Rodrigues MVB, Carvalho JTGd, Baldivia DdS, Leite DF, Santos HFd, Oliveira AS, et al. Lipid-Lowering and Anti-Inflammatory Effects of Campomanesia adamantium Leaves in Adipocytes and Caenorhabditis elegans. Pharmaceuticals. 2024; 17(8):1062. https://doi.org/10.3390/ph17081062

Chicago/Turabian Style

Rocha, Paola dos Santos da, Sarah Lam Orué, Isamara Carvalho Ferreira, Priscilla Pereira de Toledo Espindola, Maria Victória Benites Rodrigues, José Tarcísio Giffoni de Carvalho, Debora da Silva Baldivia, Daniel Ferreira Leite, Helder Freitas dos Santos, Alex Santos Oliveira, and et al. 2024. "Lipid-Lowering and Anti-Inflammatory Effects of Campomanesia adamantium Leaves in Adipocytes and Caenorhabditis elegans" Pharmaceuticals 17, no. 8: 1062. https://doi.org/10.3390/ph17081062

APA Style

Rocha, P. d. S. d., Orué, S. L., Ferreira, I. C., Espindola, P. P. d. T., Rodrigues, M. V. B., Carvalho, J. T. G. d., Baldivia, D. d. S., Leite, D. F., Santos, H. F. d., Oliveira, A. S., Campos, J. F., dos Santos, E. L., & de Picoli Souza, K. (2024). Lipid-Lowering and Anti-Inflammatory Effects of Campomanesia adamantium Leaves in Adipocytes and Caenorhabditis elegans. Pharmaceuticals, 17(8), 1062. https://doi.org/10.3390/ph17081062

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop